Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Workflow (Discovery, Development), By Mode (In-house, Outsourced), By Services, By Region, Vendor Landscape, And Segment Forecasts, 2018 - 2025

  • ID: 4582042
  • Report
  • 150 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Certara, L.P.
  • ChemBridge Corporation
  • Infosys Ltd.
  • NOVO INFORMATICS PVT. LTD
  • PerkinElmer, Inc.
  • Selvita
  • MORE
The global drug discovery informatics market size is expected to reach USD 2.07 billion by 2025, progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.

Cardiovascular Diseases (CVDs), stroke, and cancer are the most prevalent health issues and also the most common conditions causing death. Moreover, treatment expenses and costs pertaining to these diseases are very high, which triggers the demand for effective novel molecules. In the U.S. alone, revenue generated through CVD treatments was over USD 444 billion in 2010, and it has been estimated to claim more lives each year than the remaining causes of death combined.

Clinical decision support tools, which include online database for assistance in enhancement of clinical decisions, are timely updated and that significantly impacts market growth. Moreover, the World Health Organization's Consultative Expert Working Group for Research and Development is also involved in evaluation and development of open source drug discovery platforms. Introduction of open drug discovery tool kit (ODDT), which serves as a tool for computer-aided drug discovery by implementing machine learning scoring functions (RF-Score and NN-Score), is anticipated to work in favor of the market.

Further key findings from the report suggest:
  • Lead generation and lead optimization are anticipated to witness hand-in-hand growth owing to usage of similar IT solutions
  • Presence of different co-operation models, such as joint ventures, strategic partnership, price competition, and project selection, for outsourcing drug informatics solutions in the industry is influencing the growth of the market positively
  • North America is projected to hold prominent position in the arena throughout the forecast period. Higher incidence rates of different infectious diseases and oncology diseases are expected to drive the demand for informatics solutions to aid drug discovery and development. Presence of molecular R&D laboratories and market players in the U.S. is supplementing the growth of the regional market
  • Asia Pacific is likely to post the highest CAGR during the same period, owing to cost saving advantage offered by the region
  • Some of the key players operating in the market Boehringer Ingelheim GmBh; ChemAxon; Jubilant Biosys; Certara; Selvita; Novo Informatics; Albany Molecular Research Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK Biosciences; and Charles River Laboratories.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Certara, L.P.
  • ChemBridge Corporation
  • Infosys Ltd.
  • NOVO INFORMATICS PVT. LTD
  • PerkinElmer, Inc.
  • Selvita
  • MORE
Chapter 1 Research Methodology
1.1 Information procurement
1.2 List of Data Sources
1.3 Information or Data Analysis
1.4 Market Formulation & Validation

Chapter 2 Executive Summary

Chapter 3 Drug Discovery Informatics Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2014 - 2025 (USD Million)
3.3 Drug discovery informatics market dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing adoption of in-silico modeling tools
3.3.1.2 Advancements in high-performance computing and web services
3.3.1.3 Growing volume of drug discovery data
3.3.1.4 Growth in demand for novel drug moieties
3.3.2 Market restraint analysis
3.3.2.1 Downward pricing pressure and outsourcing for services
3.3.2.2 Intellectual property protection and public policy issues
3.3.2.3 Presence of open-source software packages for drug discovery
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized based on workflow steps, 2016
3.4.2 Key opportunities prioritized based services, 2016
3.4.3 Informatic service application in workflow segments, 2016
3.5 Industry analysis – Porter’s
3.6 Drug discovery informatics PESTEL Analysis

Chapter 4 Drug Discovery Informatics Workflow Outlook
4.1 Global drug discovery informatics revenue share, by workflow, 2016 & 2025
4.2 Discovery informatics
4.2.1 Discovery informatics market, 2014 - 2025 (USD Million)
4.2.2 Identification, validation, & assay development informatics
4.2.2.1 Identification, validation & assay development informatics market, 2014 - 2025 (USD Million)
4.2.3 Lead generation informatics
4.2.3.1 Lead generation informatics market, 2014 - 2025 (USD Million)
4.3 Development informatics
4.3.1 Development informatics market, 2014 - 2025 (USD Million)
4.3.2 Lead optimization
4.3.2.1 Lead optimization market, 2014 - 2025 (USD Million)
4.3.3 FHD preparation
4.3.3.1 FHD preparation market, 2014 - 2025 (USD Million)
4.3.4 Phase IA informatics
4.3.4.1 Phase IA informatics market, 2014 - 2025 (USD Million)
4.3.5 Phase IB/2 informatics
4.3.5.1 Phase IB/2 informatics market, 2014 - 2025 (USD Million)

Chapter 5 Drug Discovery Informatics Mode Outlook
5.1 Global drug discovery informatics revenue share, by mode, 2016 & 2025
5.2 Outsourced Informatics
5.2.1 Outsourced informatics market, 2014 - 2025 (USD Million)
5.3 In-house informatics
5.3.1 In-house informatics market, 2014 - 2025 (USD Million)

Chapter 6 Drug Discovery Informatics Service Outlook
6.1 Global drug discovery informatics revenue share, by service, 2016 & 2025
6.2 Sequence analysis platforms
6.2.1 Sequence analysis platforms market, 2014 - 2025 (USD Million)
6.3 Molecular Modelling
6.3.1 Molecular modelling market, 2014 - 2025 (USD Million)
6.4 Docking
6.4.1 Docking market, 2014 - 2025 (USD Million)
6.5 Clinical trial data management
6.5.1 Clinical trial data management market, 2014 - 2025 (USD Million)
6.6 Other services
6.6.1 Other services market, 2014 - 2025 (USD Million)

Chapter 7 Drug Discovery Informatics Regional Outlook
7.1 Global drug discovery informatics revenue share, by region, 2016 & 2025
7.2 North America
7.2.1 North America drug discovery informatics market, 2014 - 2025 (USD Million)
7.2.2 U.S
7.2.2.1 U.S. drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.2.2.2 U.S. drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.2.2.3 U.S. drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.2.3.2 Canada drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.2.3.3 Canada drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe drug discovery informatics market, 2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.3.2.2 Germany drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.3.2.3 Germany drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.3.3.2 U.K. drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.3.3.3 U.K. drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific drug discovery informatics market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.4.2.2 Japan drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.4.2.3 Japan drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.4.3.2 China drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.4.3.3 China drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America drug discovery informatics market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.5.2.2 Brazil drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.5.2.3 Brazil drug discovery informatics market, by service, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA drug discovery informatics market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
7.6.2.2 South Africa drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
7.6.2.3 South Africa drug discovery informatics market, by service, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 PerkinElmer, Inc.
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Thermo Fisher Scientific, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Certara, L.P.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 NOVO INFORMATICS PVT. LTD
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.5 Collaborative Drug Discovery Inc.
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Jubilant Life Sciences Limited
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product Benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Selvita
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Charles River Laboratories International, Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 ChemBridge Corporation
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Albany Molecular Research Inc. (AMRI)
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
8.1.11 GVK Biosciences Private Limited,
8.1.11.1 Company overview
8.1.11.2 Financial performance
8.1.11.3 Product benchmarking
8.1.11.4 Strategic initiatives
8.1.12 Infosys Ltd.
8.1.12.1 Company overview
8.1.12.2 Financial performance
8.1.12.3 Product benchmarking
8.1.12.4 Strategic initiatives

List of Tables
Table 1 Drug Discovery Informatics– Industry Snapshot & Key Buying Criteria, 2014 - 2025
Table 2 Drug discovery informatics market, by work flow, 2014 - 2025 (USD Million)
Table 3 Drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 4 Drug discovery informatics market, by services, 2014 - 2025 (USD Million)
Table 5 Drug discovery informatics market, by region, 2014 - 2025 (USD Million)
Table 6 Drug discovery informatics key market driver analysis
Table 7 Drug discovery informatics key market restraint analysis
Table 8 North America drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 9 North America discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 10 North America development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 11 North America drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 12 North America drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 13 U.S. drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 14 U.S. discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 15 U.S. development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 16 U.S. drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 17 U.S. drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 18 Canada drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 19 Canada discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 20 Canada development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 21 Canada drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 22 Canada drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 23 Europe drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 24 Europe discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 25 Europe development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 26 Europe drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 27 Europe drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 28 Germany drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 29 Germany discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 30 Germany development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 31 Germany drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 32 Germany drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 33 U.K. drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 34 U.K. discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 35 U.K. development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 36 U.K. drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 37 U.K. drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 38 Asia Pacific drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 39 Asia Pacific discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 40 Asia Pacific development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 41 Asia Pacific drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 42 Asia Pacific drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 43 Japan drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 44 Japan discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 45 Japan development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 46 Japan drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 47 Japan drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 48 China drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 49 China discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 50 China development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 51 China drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 52 China drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 53 Latin America drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 54 Latin America discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 55 Latin America development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 56 Latin America drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 57 Latin America drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 58 Brazil drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 59 Brazil discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 60 Brazil development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 61 Brazil drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 62 Brazil drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 63 MEA drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 64 MEA discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 65 MEA development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 66 MEA drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 67 MEA drug discovery informatics market, by service, 2014 - 2025 (USD Million)
Table 68 South Africa drug discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 69 South Africa discovery informatics market, by workflow, 2014 - 2025 (USD Million)
Table 70 South Africa development informatics market, by workflow, 2014 - 2025 (USD Million)
Table 71 South Africa drug discovery informatics market, by mode, 2014 - 2025 (USD Million)
Table 72 South Africa drug discovery informatics market, by service, 2014 - 2025 (USD Million)

List of Figures
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Drug discovery informatics market segmentation
FIG. 8 Global drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 9 Drug discovery informatics market dynamics
FIG. 10 Potential reasons for the failure of a candidate molecule
FIG. 11 Different cooperation models implemented for the outsourcing of informatic services
FIG. 12 Key opportunities prioritized, workflow steps, 2016
FIG. 13 Key opportunities prioritized, services, 2016
FIG. 14 Informatic service application in workflow segments, 2016
FIG. 15 Drug discovery informatics market Porter’s analysis
FIG. 16 Drug discovery informatics market PESTEL analysis
FIG. 17 Drug discovery informatics revenue share, by workflow, 2016 & 2025
FIG. 18 Discovery informatics market , 2014 - 2025 (USD Million)
FIG. 19 Identification, validation & assay development informatics market , 2014 - 2025 (USD Million)
FIG. 20 Lead generation informatics market , 2014 - 2025 (USD Million)
FIG. 21 Development informatics market, 2014 - 2025 (USD Million)
FIG. 22 Lead optimization market, 2014 - 2025 (USD Million)
FIG. 23 FHD preparation market, 2014 - 2025 (USD Million)
FIG. 24 Phase IA informatics market, 2014 - 2025 (USD Million)
FIG. 25 Phase IB/2 informatics market, 2014 - 2025 (USD Million)
FIG. 26 Drug discovery informatics revenue share, by mode, 2016 & 2025
FIG. 27 Outsourced informatics market , 2014 - 2025 (USD Million)
FIG. 28 In-house informatics market , 2014 - 2025 (USD Million)
FIG. 29 Drug discovery informatics revenue share, by service, 2016 & 2025
FIG. 30 Cost per raw Mega Base (Mb) of DNA sequence
FIG. 31 Cost per genome sequencing
FIG. 32 Sequence analysis platforms market , 2014 - 2025 (USD Million)
FIG. 33 Molecular modelling market , 2014 - 2025 (USD Million)
FIG. 34 Docking market , 2014 - 2025 (USD Million)
FIG. 35 Clinical trial data management market , 2014 - 2025 (USD Million)
FIG. 36 Other services market , 2014 - 2025 (USD Million)
FIG. 37 Global drug discovery informatics market share, by region, 2016 & 2025
FIG. 38 North America drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 39 U.S. drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 40 Canada drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 41 Europe drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 42 Germany drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 43 U.K. drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 44 Asia Pacific drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 45 Japan drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 46 China drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 47 Latin America drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 48 Brazil drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 49 MEA drug discovery informatics market, 2014 - 2025 (USD Million)
FIG. 50 South Africa drug discovery informatics market, 2014 - 2025 (USD Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Certara, L.P.
  • NOVO INFORMATICS PVT. LTD
  • Collaborative Drug Discovery Inc.
  • Jubilant Life Sciences Limited
  • Selvita
  • Charles River Laboratories International, Inc.
  • ChemBridge Corporation
  • Albany Molecular Research Inc. (AMRI)
  • GVK Biosciences Private Limited,
  • Infosys Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll